Clinical trial

Tirzepatide Weight Loss for MRD+ Early Breast Cancer

NCT06517212

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2024-11-26

PhasePHASE2

Study timeline

Study start (actual)2024-11-26Date precision: day

Registry last updated2026-02-12

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Breast Cancerunresolved

Breast Neoplasmsunresolved

Breast Cancersunresolved

Interventions

TirzepatideDRUG · verified · RxNorm: tirzepatide

Sponsors & collaborators

Baylor Research Institutelead sponsor

Mapped research locations

DallasTexas, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06517212 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.